Cases 11 - 20 of 166
Eli Lilly and Company et al v. Aurobindo Pharma Limited et al
as 1:2022cv01114
Plaintiff:
Eli Lilly & Company, Incyte Corporation, Incyte Holdings Corporation and others
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
as 1:2022cv00971
Plaintiff:
Covis Pharma GmbH, AMAG Pharma USA, Inc. and AMAG Pharmaceuticals, Inc.
Defendant:
Eugia Pharma Specialties Ltd., Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Takeda Pharmaceuticals U.S.A., Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv00911
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc. and Takeda Pharmaceutical Company Ltd.
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Nightmist IP LLC v. LG Electronics U.S.A., Inc.
as 1:2022cv00868
Plaintiff:
Nightmist IP LLC
Defendant:
LG Electronics U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al
as 1:2022cv00728
Plaintiff:
Vertex Pharmaceuticals Incorporated
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vibrant Licensing LLC v. LG Electronics U.S.A. Inc.
as 1:2022cv00126
Plaintiff:
Vibrant Licensing LLC
Defendant:
LG Electronics U.S.A. Inc.
Cause Of Action: 35 U.S.C. § 271
Allergan, Inc. v. Aurobindo Pharma Limited et al
as 1:2021cv01808
Plaintiff:
Allergan, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Limited
Cause Of Action: 35 U.S.C. § 271
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Taro Pharmaceutical Industries Ltd. et al v. Encube Ethicals Pvt. Ltd.
as 1:2021cv01614
Counter Defendant:
Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals North America, Inc. and Taro Pharmaceuticals U.S.A., Inc.
Defendant:
Encube Ethicals Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 1
TOT Power Control, S.L. v. LG Electronics, Inc. et al
as 1:2021cv01304
Plaintiff:
TOT Power Control, S.L.
Defendant:
LG Electronics, Inc. and LG Electronics U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
